Kishimoto T, Sato T, Ono T, Takahashi K, Kimura I
Department of Clinical Investigation, Kure Kyosai Hospital, Japan.
Br J Clin Pract. 1990 Jun;44(6):226-30.
Blood eosinophils obtained from 25 patients with bronchial asthma were reacted with anti-IgG or with normal rabbit serum as the control. Morphological changes were examined by light microscopy, scanning electron microscopy and transmission electron microscopy. Reactive eosinophils in morphology with anti-IgG (27.8 per cent) were significantly higher (p less than 0.001) than those with the control (1.2 per cent). We also examined the effects of ketotifen and tranilast, both of which have eosinophil chemotactic inhibitory functions, on the morphological changes. Ketotifen altered the morphological reactivation of eosinophils and the generation of leukotrienes induced by anti-IgG, and this inhibition occurred in a concentration-dependent manner. Tranilast had no effect on the morphology of eosinophils and the generation of leukotrienes. These results suggest that eosinophil IgG receptors may have a role in the pathogenesis of asthma and that ketotifen may prevent their reactivity and, thus, could be of potential use in the treatment of asthma.
从25例支气管哮喘患者获取的血液嗜酸性粒细胞与抗IgG反应,或与作为对照的正常兔血清反应。通过光学显微镜、扫描电子显微镜和透射电子显微镜检查形态学变化。与抗IgG反应的嗜酸性粒细胞在形态学上的反应性(27.8%)显著高于对照组(1.2%)(p<0.001)。我们还研究了都具有嗜酸性粒细胞趋化抑制功能的酮替芬和曲尼司特对形态学变化的影响。酮替芬改变了嗜酸性粒细胞的形态再激活以及抗IgG诱导的白三烯生成,且这种抑制呈浓度依赖性。曲尼司特对嗜酸性粒细胞形态和白三烯生成无影响。这些结果表明,嗜酸性粒细胞IgG受体可能在哮喘发病机制中起作用,且酮替芬可能阻止其反应性,因此可能在哮喘治疗中具有潜在用途。